Corient Capital Partners, LLC Thermo Fisher Scientific Inc. Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 8,173 shares of TMO stock, worth $4.19 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

8,173

Previous 8,173 -0.0%

Holding current value

$4.19 Million

Previous $4.44 Million -0.0%

% of portfolio

0.33%

Previous 0.34%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$500.9 - $612.21 $431,274 - $527,112	861 Added 11.78%	8,173 $4.44 Million
Q1 2022 May 16, 2022	BUY	$524.0 - $644.92 $159,296 - $196,055	304 Added 4.34%	7,312 $4.32 Million
Q4 2021 Feb 11, 2022	BUY	$569.0 - $667.24 $113,800 - $133,448	200 Added 2.94%	7,008 $4.68 Million
Q3 2021 Nov 16, 2021	BUY	$509.53 - $609.78 $187,507 - $224,399	368 Added 5.71%	6,808 $3.89 Million
Q2 2021 Aug 16, 2021	BUY	$441.0 - $508.24 $164,052 - $189,065	372 Added 6.13%	6,440 $3.25 Million
Q1 2021 May 17, 2021	BUY	$439.85 - $518.83 $95,447 - $112,586	217 Added 3.71%	6,068 $2.77 Million
Q4 2020 Feb 12, 2021	SELL	$435.06 - $527.66 $1.11 Million - $1.35 Million	-2,551 Reduced 30.36%	5,851 $2.73 Million
Q3 2020 Nov 16, 2020	SELL	$359.77 - $441.52 $49,648 - $60,929	-138 Reduced 1.62%	8,402 $3.71 Million
Q2 2020 Aug 14, 2020	BUY	$275.2 - $362.34 $243,552 - $320,670	885 Added 11.56%	8,540 $3.09 Million
Q1 2020 May 06, 2020	BUY	$255.3 - $340.05 $271,383 - $361,473	1,063 Added 16.13%	7,655 $2.17 Million
Q4 2019 Feb 04, 2020	BUY	$271.93 - $328.04 $37,526 - $45,269	138 Added 2.14%	6,592 $2.14 Million
Q3 2019 Nov 06, 2019	BUY	$268.46 - $305.43 $265,238 - $301,764	988 Added 18.08%	6,454 $1.88 Million
Q2 2019 Aug 08, 2019	BUY	$257.51 - $295.55 $76,222 - $87,482	296 Added 5.73%	5,466 $1.61 Million
Q1 2019 May 10, 2019	BUY	$212.17 - $273.72 $440,040 - $567,695	2,074 Added 66.99%	5,170 $1.42 Million
Q4 2018 Feb 07, 2019	BUY	$208.47 - $251.98 $251,414 - $303,887	1,206 Added 63.81%	3,096 $693,000
Q2 2018 Oct 02, 2018	BUY	$203.14 - $219.53 $41,440 - $44,784	204 Added 12.1%	1,890 $392,000
Q1 2018 May 14, 2018	BUY	$192.98 - $224.11 $5,403 - $6,275	28 Added 1.69%	1,686 $348,000
Q4 2017 Feb 13, 2018	BUY	$182.03 - $200.37 $35,131 - $38,671	193 Added 13.17%	1,658 $315,000
Q3 2017 Nov 14, 2017	SELL	$171.74 - $194.04 $3,950 - $4,462	-23 Reduced 1.55%	1,465 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-180 Reduced 10.79%	1,488 $260,000
Q1 2017 Aug 17, 2017	SELL	N/A	-8,432 Reduced 83.49%	1,668 $256,000
Q1 2017 Aug 14, 2017	BUY	N/A	10,100	10,100 $291,000

Others Institutions Holding TMO

# of Institutions

2,829

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Thermo Fisher Scientific Inc. Transaction History